Skip to main content
. 2009 Jun 17;100(9):1748–1756. doi: 10.1111/j.1349-7006.2009.01244.x

Table 2.

Summary of immunohistochemical analysis of invasive or in situ breast carcinomas and benign breast tissue using Alper‐p280 anti‐filamin‐A monoclonal antibody. Filamin‐A is expressed mostly on invasive carcinomas

Sample classification Number of cases 3+ 2+ 1+ or negative
Benign/normal 35 1  8 26
DCIS/LCIS 10 1  2  7
Invasive carcinoma (DCIS, n = 18; LCIS, n = 2) 20 7 10  3

DCIS, ductal carcinoma in situ; LCIS, lobular carcinoma in situ.